Liposome-Encapsulated Berberine Alleviates Liver Injury in Type 2 Diabetes via Promoting AMPK/mTOR-Mediated Autophagy and Reducing ER Stress: Morphometric and Immunohistochemical Scoring

• Váldodahkkit: Safaa I. Khater (Dahkki), Taghreed N. Almanaa (Dahkki), Doaa M. Abdel Fattah (Dahkki), Tarek Khamis (Dahkki), Mona M. Seif (Dahkki), Naief Dahran (Dahkki), Leena S. Alqahtani (Dahkki), Mohamed M. M. Metwally (Dahkki), Mahmoud Mostafa (Dahkki), Raghad A. Albedair (Dahkki), Azza I. Helal (Dahkki), Manal Alosaimi (Dahkki), Amany Abdel-Rahman Mohamed (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2023-06-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

In the advanced stages of type 2 diabetes mellitus (T2DM), diabetic liver damage is a common complication that can devastate a patient's quality of life. The present study investigated the ability of liposomal berberine (Lip-BBR) to aid in ameliorating hepatic damage and steatosis, insulin home...